| Dr Jenna Beth Mackay, DPM | |
|
1506 Ne Williamson Blvd, Bend, OR 97701-6071 | |
| (541) 383-3668 | |
| Not Available |
| Full Name | Dr Jenna Beth Mackay |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 8 Years |
| Location | 1506 Ne Williamson Blvd, Bend, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689029936 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | DP214043 (Idaho) | Secondary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | DP214043 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Laura A Schweger Pc | 9133126113 | 3 |
News Archive
Care homes and home care providers will benefit from a new £162.5 million workforce retention and recruitment fund to bolster the dedicated care workforce.
Vivakor, Inc. announced today that its Board of Directors approved a dividend of shares of common stock of Regeneca International, Inc.. Vivakor previously received the shares from Regeneca in the fourth quarter of 2009 under a license agreement whereby Vivakor exclusively licensed to Regeneca, for the direct to consumer market, distribution rights to RegeneBlend, one of the new cutting-edge nutraceutical formulations developed by Vivakor.
MedImmune today announced an in-licensing agreement with Amgen for a novel monoclonal antibody targeting the IL-1 pathway. The antibody, AMG 108, a fully human monoclonal antibody to the IL-1 receptor, has been studied in multiple phase 1 and phase 2 clinical trials and will now be explored by MedImmune for its potential against certain inflammatory diseases.
Major depressive disorder is highly prevalent, with one in five people experiencing an episode at some point in their life, and is almost twice as common in women than in men.
› Verified 6 days ago
| Provider Name | Laura A Schweger Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1497831960 PECOS PAC ID: 9133126113 Enrollment ID: O20061113000088 |
News Archive
Care homes and home care providers will benefit from a new £162.5 million workforce retention and recruitment fund to bolster the dedicated care workforce.
Vivakor, Inc. announced today that its Board of Directors approved a dividend of shares of common stock of Regeneca International, Inc.. Vivakor previously received the shares from Regeneca in the fourth quarter of 2009 under a license agreement whereby Vivakor exclusively licensed to Regeneca, for the direct to consumer market, distribution rights to RegeneBlend, one of the new cutting-edge nutraceutical formulations developed by Vivakor.
MedImmune today announced an in-licensing agreement with Amgen for a novel monoclonal antibody targeting the IL-1 pathway. The antibody, AMG 108, a fully human monoclonal antibody to the IL-1 receptor, has been studied in multiple phase 1 and phase 2 clinical trials and will now be explored by MedImmune for its potential against certain inflammatory diseases.
Major depressive disorder is highly prevalent, with one in five people experiencing an episode at some point in their life, and is almost twice as common in women than in men.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jenna Beth Mackay, DPM 1506 Ne Williamson Blvd, Bend, OR 97701-6071 Ph: (541) 383-3668 | Dr Jenna Beth Mackay, DPM 1506 Ne Williamson Blvd, Bend, OR 97701-6071 Ph: (541) 383-3668 |
News Archive
Care homes and home care providers will benefit from a new £162.5 million workforce retention and recruitment fund to bolster the dedicated care workforce.
Vivakor, Inc. announced today that its Board of Directors approved a dividend of shares of common stock of Regeneca International, Inc.. Vivakor previously received the shares from Regeneca in the fourth quarter of 2009 under a license agreement whereby Vivakor exclusively licensed to Regeneca, for the direct to consumer market, distribution rights to RegeneBlend, one of the new cutting-edge nutraceutical formulations developed by Vivakor.
MedImmune today announced an in-licensing agreement with Amgen for a novel monoclonal antibody targeting the IL-1 pathway. The antibody, AMG 108, a fully human monoclonal antibody to the IL-1 receptor, has been studied in multiple phase 1 and phase 2 clinical trials and will now be explored by MedImmune for its potential against certain inflammatory diseases.
Major depressive disorder is highly prevalent, with one in five people experiencing an episode at some point in their life, and is almost twice as common in women than in men.
› Verified 6 days ago
Dr. Amanda Westfall Mccarty, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1693 Sw Chandler Ave, Suite 280, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 | |
Northwest Footcare, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 1693 Sw Chandler Ave, Ste 280, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 | |
Antonia Lynn Mcclune, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1501 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-4900 | |
Dr. Laura Schweger Savage, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1506 Ne Williamson Blvd, Bend, OR 97701 Phone: 541-383-3668 Fax: 541-383-4546 | |
Tajyant Nat Chotechuang, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1510 Sw Nancy Way Ste 2, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 | |
Bryan Wilhelm, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1510 Sw Nancy Way Ste 2, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 | |
Dr. Frank Robert Cobarrubia, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1510 Sw Nancy Way Ste 2, Bend, OR 97702 Phone: 541-385-7129 Fax: 541-385-7138 |